Literature DB >> 3344887

Multicentric angiofollicular lymph node hyperplasia. Pathology of the spleen.

D D Weisenburger1.   

Abstract

Splenomegaly is a frequent clinical finding in multicentric angiofollicular lymph node hyperplasia (MAFH). However, pathologic descriptions of the spleen in MAFH have been reported in only a few cases. The author studied the spleens of seven patients with MAFH (two hyaline-vascular type and five plasma cell type) and reviewed the literature on the pathology of the spleen in this disorder. The histologic features of the seven spleens paralleled those of the lymph nodes. The two hyaline-vascular cases were characterized by white pulp hyperplasia with numerous atrophic and hyaline-vascular germinal centers, and rare plasma cells. In contrast, four plasma cell cases exhibited white pulp hyperplasia with a spectrum of germinal centers ranging from large, hyperplastic centers to typical hyaline-vascular centers, and prominent plasmacytosis. Marked white pulp fibrosis with severe lymphocyte depletion was seen in the fifth plasma cell case, and marginal zone fibrosis with prominent plasmacytosis was seen in one of the other plasma cell cases. The author concludes that the presence of altered germinal centers, white pulp or marginal zone fibrosis, and prominent plasmacytosis should suggest a diagnosis of MAFH in the spleen.

Entities:  

Mesh:

Year:  1988        PMID: 3344887     DOI: 10.1097/00000478-198803000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 2.  Castleman's disease: systematic analysis of 416 patients from the literature.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Oncologist       Date:  2011-07-17

3.  Increased erythrocyte sedimentation rate and a splenic mass.

Authors:  J V Hirschmann; S Patterson; J G Drachman; H Rosen; W C Liles
Journal:  West J Med       Date:  1994-12

4.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

Review 5.  A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Authors:  Alexandra Butzmann; Jyoti Kumar; Kaushik Sridhar; Sumanth Gollapudi; Robert S Ohgami
Journal:  Biology (Basel)       Date:  2021-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.